The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Screening of neoantigen-specific T cells and establishment of T-cell receptor-engineered T cells: Implications for head and neck squamous carcinoma.
 
Lili Ren
No Relationships to Disclose
 
Tatsuo Matsuda
No Relationships to Disclose
 
Boya Deng
No Relationships to Disclose
 
Kazuma Kiyotani
No Relationships to Disclose
 
Taigo Kato
No Relationships to Disclose
 
Jae-Hyun Park
Employment - OncoTherapy Science
Consulting or Advisory Role - OncoTherapy Science
Research Funding - OncoTherapy Science
 
Tanguy Y. Seiwert
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Innate Pharma; Jounce Therapeutics; Lilly; Merck; Merck Serono
Research Funding - Boehringer Ingelheim (Inst); Genentech/Roche (Inst)
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Amgen; ARIAD; AstraZeneca; Bayer; Biolumina; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Leidos Biomedical Research; Lilly; Merck; Novartis; Regeneron; Takeda; VentiRx
 
Nishant Agrawal
No Relationships to Disclose
 
Yusuke Nakamura
Stock and Other Ownership Interests - OncoTherapy Science
Consulting or Advisory Role - FRONTEO Healthcare; OncoTherapy Science
Research Funding - OncoTherapy Science
Patents, Royalties, Other Intellectual Property - I have nearly 100 patents with University Tokyo and OncoTherapy Science. I have had no patent royalty from the company yet.